Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus and Warfarin for Refractory PNH
NCT03866681Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sirolimus in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Peking Union Medical College Hospital. Primary endpoint: Hemoglobin at 2 years. Status: unknown.
02
Drugs
sirolimus
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT03866681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03866681.